Home Cart Sign in  
Chemical Structure| 19983-44-9 Chemical Structure| 19983-44-9

Structure of Stattic
CAS No.: 19983-44-9

Chemical Structure| 19983-44-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Stattic emerges as a potent STAT3 inhibitor, effectively inhibiting STAT3 phosphorylation (at Y705 and S727). It further inhibits the binding of a high-affinity phosphopeptide for the SH2 domain of STAT3 and ameliorates renal dysfunction in Alport syndrome (AS) mice.

Synonyms: STAT3 Inhibitor V

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Stattic

CAS No. :19983-44-9
Formula : C8H5NO4S
M.W : 211.19
SMILES Code : O=[N+](C1=CC=C(C=CS2(=O)=O)C2=C1)[O-]
Synonyms :
STAT3 Inhibitor V
MDL No. :MFCD00173799
InChI Key :ZRRGOUHITGRLBA-UHFFFAOYSA-N
Pubchem ID :2779853

Safety of Stattic

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Stattic

JAK-STAT

Isoform Comparison

Biological Activity

Description
Stattic acts as a potent inhibitor of STAT3 and impedes STAT3 phosphorylation at Y705 and S727 [1].
Target
  • STAT3

    STAT3, IC50:5.1 μM

In Vitro:

Cell Line
Concentration Treated Time Description References
CD11b+Ly6G− cells 10 μM 2 h inhibits STAT3 activation and nuclear translocation J Am Heart Assoc. 2020 Sep 15;9(18):e017071.
BMDMs 10 μM 24 h Inhibited STAT3 activation and downregulated CD206 and Il-10 expression Gut Microbes. 2022 Jan-Dec;14(1):2145843.
THP-1 cells 5 μM 1 hour Stattic inhibited TNC-induced STAT3 activation and TNF-α production Cancer Res. 2019 May 15;79(10):2697-2708.
MDA-MB-231 cells 10 μmol/ml 12 h Stattic treatment significantly inhibited CAF-induced MDA-MB-231 cell colony formation and reversed CAF-induced radioresistance Cell Death Discov. 2023 Jan 13;9(1):6.
MCF-7 cells 10 μmol/ml 12 h Stattic treatment significantly inhibited CAF-induced MCF-7 cell colony formation and reversed CAF-induced radioresistance Cell Death Discov. 2023 Jan 13;9(1):6.
T47D cells 10 μmol/ml 12 h Stattic treatment significantly inhibited CAF-induced T47D cell colony formation and reversed CAF-induced radioresistance Cell Death Discov. 2023 Jan 13;9(1):6.
HT-29 cells 10 μM 24 h To examine the effect of Stattic on STAT3 activity, results showed that Stattic inhibited STAT3 activity. Theranostics. 2018 Apr 30;8(11):3022-3037.
Caco-2 cells 10 μM 24 h To examine the effect of Stattic on STAT3 activity, results showed that Stattic inhibited STAT3 activity. Theranostics. 2018 Apr 30;8(11):3022-3037.
HPV-KER cells 5 µM 1 hour To study the effect of Stattic on the STAT3 signaling pathway in HPV-KER cells Front Immunol. 2018 Sep 24;9:2155.
RAW264.7 macrophages 10 nmol/mL 1 hour Stattic almost entirely abrogated TGF-β1–induced PD-1 expression in macrophages JCI Insight. 2024 Mar 5;9(7):e165544.
Raw264.7 cells 10 μM 24 h Inhibited STAT3 activation and downregulated CD206 and Il-10 expression Gut Microbes. 2022 Jan-Dec;14(1):2145843.
786-O cells 5 μM 24 h Stattic effectively inhibited STAT3 in the presence of BEZ235, significantly enhancing the anti-proliferative effects of BEZ235 on PTEN-deficient cancer cells. Oncogenesis. 2021 Jan 5;10(1):8.
MDA-MB-436 cells 5 μM 24 h Stattic effectively inhibited STAT3 in the presence of BEZ235, significantly enhancing the anti-proliferative effects of BEZ235 on PTEN-deficient cancer cells. Oncogenesis. 2021 Jan 5;10(1):8.
HGC-27 cells 5 μM 24 h Stattic effectively inhibited STAT3 in the presence of BEZ235, significantly enhancing the anti-proliferative effects of BEZ235 on PTEN-deficient cancer cells. Oncogenesis. 2021 Jan 5;10(1):8.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Myocardial infarction model Intraperitoneal injection 20 mg/kg Daily for 3 days Inhibits STAT3 phosphorylation, reduces the number of MerTK+ galectin-3hi macrophages J Am Heart Assoc. 2020 Sep 15;9(18):e017071.
Mice TGF-β1-induced chronic inflammation model Intraperitoneal injection 75 μg/mouse For 5 consecutive days Stattic completely abrogated TGF-β1–induced PD-1 expression on peritoneal macrophages JCI Insight. 2024 Mar 5;9(7):e165544.
Mice DSS-induced acute colitis model Intraperitoneal injection 4 mg/kg Once every two days for 14 days Inhibited STAT3 activation and attenuated the anti-inflammatory effect of L. johnsonii Gut Microbes. 2022 Jan-Dec;14(1):2145843.
Nude mice HGC-27 and MDA-MB436 xenograft models Intra-peritoneally 3.75 mg/kg Daily for 20 days Combination treatment with BEZ235 and Stattic significantly inhibited the growth of HGC-27 and MDA-MB436 xenograft tumors, and the combination was more effective than BEZ235 alone. Oncogenesis. 2021 Jan 5;10(1):8.

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

4.74mL

0.95mL

0.47mL

23.68mL

4.74mL

2.37mL

47.35mL

9.47mL

4.74mL

References

 

Historical Records

Categories